Skip to content
The 10-year-old girl was cheerful and upbeat as she spoke to a group of strangers online, but she was also disarmingly clear-eyed about the […]
Children with rare diseases advocate for legislation in online panel Read More »
Legislation to increase transparency of pharmacy benefit managers (PBMs), and to reauthorize the Pediatric Priority Review Voucher (PPRV), the Pandemic All Hazards Preparedness Act
Congress set to pass PBM reform and extensions of PPRV, PAHPA, Farm Bill Read More »
Proposed federal rules on exchange of medical data with China and five other “countries of concern” can protect Americans without obstructing the global flow
Data transfer rules don’t have to hamper biotech innovation, BIO says Read More »
Pharmacy benefit managers (PBMs) create unnecessary barriers between patients and the medicine they need, experts explained during a Nov. 25 virtual “Patient Advocacy Coffee
Harms of PBMs explained in BIO Patient Advocacy Coffee Chat Read More »
As biotech breakthroughs enable remarkable advances in treatment and prevention of disease, we need similar levels of innovation in access, so patients benefit from
BIO CEO John F. Crowley calls for innovation in access at Milken Health Summit Read More »
Biotech firms weighing an initial public offering (IPO) must consider timing, interest in their product, the macro environment—and whether they really need all the
BIO Investor Forum panel breaks down when, what, and why of IPOs Read More »
The tide has been rising in biotech investment in 2024—though it has not lifted all boats equally. While the volume of investment improved in
BIO Investor Forum opens with encouraging news on financing Read More »
Colorado’s efforts to impose price controls on prescription drugs are preempted by federal law, according to a legal brief by the Biotechnology Innovation Organization
Colorado price-setting board conflicts with federal law, BIO tells court Read More »
Food and Drug Administration (FDA) inaction on patents for drug delivery devices has been troubling drug manufacturers for 20 years, and the situation is
Sen. Cassidy calls on FDA to act, not abdicate, on drug device patents Read More »
As Claudia Sheinbaum became Mexico’s president on Oct. 1, a bipartisan letter from 21 American Congress members called on U.S. officials to resolve the
As Mexico changes presidents, House members urge action on corn ban Read More »
